193 related articles for article (PubMed ID: 32446902)
21. Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies.
Sarkar M; Saha S
PLoS One; 2020; 15(8):e0237300. PubMed ID: 32785274
[TBL] [Abstract][Full Text] [Related]
22. An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human-pathogenic coronavirus (SARS-CoV-2).
Cárdenas-Conejo Y; Liñan-Rico A; García-Rodríguez DA; Centeno-Leija S; Serrano-Posada H
J Med Virol; 2020 Jun; 92(6):688-692. PubMed ID: 32167166
[TBL] [Abstract][Full Text] [Related]
23. Comparing the binding properties of peptides mimicking the Envelope protein of SARS-CoV and SARS-CoV-2 to the PDZ domain of the tight junction-associated PALS1 protein.
Toto A; Ma S; Malagrinò F; Visconti L; Pagano L; Stromgaard K; Gianni S
Protein Sci; 2020 Oct; 29(10):2038-2042. PubMed ID: 32822073
[TBL] [Abstract][Full Text] [Related]
24. Design of a Multiepitope-Based Peptide Vaccine against the E Protein of Human COVID-19: An Immunoinformatics Approach.
Abdelmageed MI; Abdelmoneim AH; Mustafa MI; Elfadol NM; Murshed NS; Shantier SW; Makhawi AM
Biomed Res Int; 2020; 2020():2683286. PubMed ID: 32461973
[TBL] [Abstract][Full Text] [Related]
25. Virological assessment of hospitalized patients with COVID-2019.
Wölfel R; Corman VM; Guggemos W; Seilmaier M; Zange S; Müller MA; Niemeyer D; Jones TC; Vollmar P; Rothe C; Hoelscher M; Bleicker T; Brünink S; Schneider J; Ehmann R; Zwirglmaier K; Drosten C; Wendtner C
Nature; 2020 May; 581(7809):465-469. PubMed ID: 32235945
[TBL] [Abstract][Full Text] [Related]
26. Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic.
Nelson CW; Ardern Z; Goldberg TL; Meng C; Kuo CH; Ludwig C; Kolokotronis SO; Wei X
Elife; 2020 Oct; 9():. PubMed ID: 33001029
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans.
Nchioua R; Kmiec D; Müller JA; Conzelmann C; Groß R; Swanson CM; Neil SJD; Stenger S; Sauter D; Münch J; Sparrer KMJ; Kirchhoff F
mBio; 2020 Oct; 11(5):. PubMed ID: 33067384
[TBL] [Abstract][Full Text] [Related]
28. A SARS-CoV-2 variant with the 12-bp deletion at E gene.
Sun YS; Xu F; An Q; Chen C; Yang ZN; Lu HJ; Chen JC; Yao PP; Jiang JM; Zhu HP
Emerg Microbes Infect; 2020 Dec; 9(1):2361-2367. PubMed ID: 33118859
[TBL] [Abstract][Full Text] [Related]
29. Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection.
Mahapatra SR; Sahoo S; Dehury B; Raina V; Patro S; Misra N; Suar M
Expert Rev Vaccines; 2020 Sep; 19(9):871-885. PubMed ID: 32869699
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2.
Zheng Z; Monteil VM; Maurer-Stroh S; Yew CW; Leong C; Mohd-Ismail NK; Cheyyatraivendran Arularasu S; Chow VTK; Lin RTP; Mirazimi A; Hong W; Tan YJ
Euro Surveill; 2020 Jul; 25(28):. PubMed ID: 32700671
[TBL] [Abstract][Full Text] [Related]
31. Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients.
Li Y; Lai DY; Zhang HN; Jiang HW; Tian X; Ma ML; Qi H; Meng QF; Guo SJ; Wu Y; Wang W; Yang X; Shi DW; Dai JB; Ying T; Zhou J; Tao SC
Cell Mol Immunol; 2020 Oct; 17(10):1095-1097. PubMed ID: 32895485
[No Abstract] [Full Text] [Related]
32. Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population.
Yi Z; Ling Y; Zhang X; Chen J; Hu K; Wang Y; Song W; Ying T; Zhang R; Lu H; Yuan Z
Emerg Microbes Infect; 2020 Dec; 9(1):1988-1996. PubMed ID: 32844713
[No Abstract] [Full Text] [Related]
33. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
Tai W; He L; Zhang X; Pu J; Voronin D; Jiang S; Zhou Y; Du L
Cell Mol Immunol; 2020 Jun; 17(6):613-620. PubMed ID: 32203189
[TBL] [Abstract][Full Text] [Related]
34. How the COVID-19 Overcomes the Battle? An Approach to Virus Structure.
Ahmadpour D; Ahmadpoor P
Iran J Kidney Dis; 2020 May; 14(3):167-172. PubMed ID: 32361692
[TBL] [Abstract][Full Text] [Related]
35. COVID-19: Time to exonerate the pangolin from the transmission of SARS-CoV-2 to humans.
Frutos R; Serra-Cobo J; Chen T; Devaux CA
Infect Genet Evol; 2020 Oct; 84():104493. PubMed ID: 32768565
[TBL] [Abstract][Full Text] [Related]
36. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
[TBL] [Abstract][Full Text] [Related]
37. Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins.
Srinivasan S; Cui H; Gao Z; Liu M; Lu S; Mkandawire W; Narykov O; Sun M; Korkin D
Viruses; 2020 Mar; 12(4):. PubMed ID: 32218151
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
39. Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches.
Dong R; Chu Z; Yu F; Zha Y
Front Immunol; 2020; 11():1784. PubMed ID: 32849643
[TBL] [Abstract][Full Text] [Related]
40. Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach.
Ahammad I; Lira SS
Int J Biol Macromol; 2020 Nov; 162():820-837. PubMed ID: 32599237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
